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antiarrhythmic effect according to the drugs of group III. Thus, it 
is expected that tiapamil may be effective in preventing ventric- 
ular arrhythmias in the setting of acute myocardial ischemia. 
Preliminary results of Thandroyen et al.’ and a recent study from 
our 1aboratoryJ confirmed that tiapamil is highly effective in 
preventing coronary artery occlusion and reperfusion arrhyth- 
mias in a dog model. Kordent and Leasure’ did not report their 
observation on ventricular arrhythmia and the causes of death 
following coronary artery occlusion in their study. However, a 
careful analysis of this issue might add significantly to the 
understanding of the mechanism by which tiapamil exerts its 
beneficial effects during acute coronary occlusion. 
Shimon Braun, M.D. 
Department o/Medicine 
Cardiology Section, 111 C 
Veterans Administration Medical Center 
4150 Clement Street 
San Francisco, CA 94121 
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REPLY 
To the Editor: 
The antidysrhythmic effect of tiapamil and other calcium entry 
blocking drugs is well known. Because the goal of our study was to 
evaluate the possible protective effect of tiapamil on limiting 
infarct size, we wished to suppress this abnormal ECG conduction 
pattern that might influence this variable. Continuous intrave- 
nous lidocaine was used to maintain sinus rhythm during the 
monitoring and recording periods in both acute groups. It was not 
possible to continuously monitor the ECG through the chronic 
period of the study or to continue the intravenous lidocaine 
administration. In the animals that did not survive the 8-day 
infarction period, the deaths were assumed to be electrical. The 
antidysrhythmic effect of tiapamil could therefore not be objec- 
tively reported. I agree that rhythmic differences in the ECG 
would contribute to the evaluation of the overall protective effect 
of tiapamil in acute myocardial infarction, and if the funds to 
study this variable would be presented to us, we would be happy 
to report the results. 
Karl Kordenat, M.D. 
Wright State University 
School of Medicine 
Cox Heart Institute 
3525 Southern Boulevard 
Dayton, Ohio 45429 
December 1986 
American Heart Journal 
THE Q-WAVE AND TRANSMURAL AMI 
To the Editor: 
Buda et al.’ present interesting and potentially valuable mate- 
rial on regional left ventricular function during infarction. How- 
ever, they may have inadvertently contributed further to the 
conceptual confusion which can follow the all-too-frequent use of 
misnomers in science. There has been sufficient literature on the 
nonspecificity of the ECG for distinguishing anatomically trans- 
mural from nontransmural infarcts.2.’ Indeed, their results with Q 
wave and non-Q wave infarcts support some of the demonstrated 
differences and overlap between these two ECG categories that 
are inadequate to represent anatomy.’ This would be a mere 
t.erminologic quibble if it were not for the importance of getting 
our descriptors right. Q wave and non-Q wave infarcts do differ in 
morbidity and the secular distribution of mortality, among other 
things.’ Assuming that there is a corresponding anatomic distri- 
bution that may be responsible for this when that is incorrect, 
tends to discourage further investigation as to the real basis for 
differences. This is not in direct criticism of an otherwise 
important study. 
David H. Spodick, M.D. 
Cardiology Division 
Saint Vincent Hospital, Inc. 
Worcester, MA 01604 
REFERENCES 
1. Buda AJ, Dubbin JN, Meindok H: Radionuclide assessment 
of regional LV function in acute myocardial infarction. AM 
HEART J 1986;111:36-41. 
2. Phibbs B: “Transmural” versus “subendocardial” infarction: 
An ECG myth. J Am Co11 Cardiol 1983;1:561-4. 
3. Spodick DH: Q-wave infarction versus ST-infarction: Non- 
specificity of ECG criteria for differentiating transmural and 
nontransmural lesions. Am J Cardiol 1983;913-15. 
REPLY 
To the Editor: 
Dr. Spodick’s point is well taken, and I agree that the ECG is an 
imperfect marker of infarct localization and transmurality. Sever- 
al clinical’-’ and experimental studies4-6 document the occurrence 
of Q waves with nontransmural infarction, as well as their absence 
with transmural infarction. I am well aware of these studies, since 
it was from this Institution that Wilson et al.“,’ reported over 50 
years ago in this JOURNAL that epicardial qR waves originated 
from sites in which “the outer layers of muscle were alive and 
were responding to the excitatory process.” And, after half a 
century, these experimental observations have recently been 
reevaluated and reconfirmed.* 
However, in our defense, the terminology “transmural myocar- 
dial infarction” is traditional and continues to be employed in 
recent articles of several other prominent cardiovascular jour- 
nals.‘-9 This is not to say that this terminology is correct or 
appropriate. However, tradition has a way of fixing terminology 
despite advancing knowledge and improved understanding. We 
have used the traditional term “transmural” rather than the more 
appropriate term “Q wave” as proposed by Spodick.“’ Although I 
agree with Dr. Spodick’s choice of descriptor, the dichotomy of 
terms continues to exist, as demonstrated in the 1985 American 
Heart Association abstracts. Of 55 clinical studies indexed under 
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myocardial infarction, seven used the term “transmural” and six 
used “Q wave.” It is clear there is no consistency of terminolo- 
gy. 
Thus, our intent in using “transmural” was not to contribute 
further to the conceptual confusion, but merely to be tradition- 
al. 
Andrew J. Buda, M.D. 
Diuision of Cardiology 
University of Michigan 
Medical Center 
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ECHOGRAPHY OF PERICARDIAL MESOTHELIOMA 
To The Editor: 
Agataton et al.’ report echocardiographic findings in primary 
pericardial mesothelioma of considerable interest. I wonder if the 
authors would reexamine Fig. 2. The structure interpreted to 
show early diastolic anterior motion followed by abrupt diastasis, 
a pattern one would anticipate with restrictive physiology, 
appears to be a Swan-Ganz catheter, rather than the RV free 
wall. 
ilaud H. Spodick. MD 
(‘ardiolog>l Division 
Saint Virtcc~l~L Hospital. Inc. 
War erer. MA 0160-l 
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REPLY 
To the Editor: 
We reviewed Fig. 2 from our article “Echocardiographic tind- 
ings in primary pericardial mesothelioma“ (AM HEART J 
1986;111:986), along with the real-time two-dimensional echocar- 
diogram of our patient. It is apparent that the echo labeled “right 
ventricular free wall” is in fact the Swan-Ganz catheter. The 
underlying right ventricular free wall is hypokinetic secondary to 
pericardial and myocardial tumor. We t,hank Dr. Spodick for 
pointing out this misinterpretation. 
Arthur Agatston, M.D. 
Mount Sinai Medical Center 
4300 Alton Road 
Miami Reach. FL 33140 
CARDIAC ALPHA-RECEPTORS AND CARDIAC 
HY PERTROP4iY IN GENETIC PREOISPOSITION 
TO HYPERTENSION 
To the Editor: 
The interesting study of Radice et al.’ gives evidence for 
cardiac hypertrophy in normotensive young men with at least one 
hypertensive parent. Since the nature of myocardial alterations 
underlying the pathogenesis of this prehypertensive cardiac 
hypertrophy is still unknown and difficult to investigate in the 
human heart, it is worth using suitable animal models for 
experimental studies. Spontaneously hypertensive rats (SHR) 
develop cardiac hypertrophy before an elevated blood pressure 
can be detected.‘,’ Furthermore, Syrian hamsters of the inbred 
strain BIO 8262 with cardiomyopathy (BIO 8262) develop cardiac 
hypertrophy following myocardial necrosis before heart failure 
occurs.4 Since in both SHR and BIO 8262, cardiac hypertrophy 
occurs before the onset of hypertension or heart failure,2A these 
animal models provide strong similarities to the subjects studied 
by Radice et al.’ 
A crucial role of norepinephrine to trigger the cardiac hypertro- 
phy process is well recognized.’ Recent studies on isolated cardiac 
myocytes provide strong evidence that this effect is mediated by 
cardiac Lu-adrenoceptors.“. We now report an increased sensitivi- 
ty to stimulation of cardiac a-adrenoceptors in SHR and BIO 
8262 before the onset of hypertension and heart failure, respec- 
tively. Young SHR and BIO 8262 were investigated in the absence 
of hypertension and cardiac necrosis, respectively (i.e., twenty- 
fifth to thirty-second day of life). Age-matched Wistar rats and 
